Offer An Article

Pandemic Latest News

Roche Diagnostics India advocates preventive healthcare to minimise impact from comorbidities in COVID-19 times

Preventive healthcare, regular lab investigations key to overall health

Indian Doctor standing with stethoscope on India flag background. National healthcare system concept, medical theme. Image credit: Sezer özger / 123rf
Image credit: Sezer özger / 123rf

Mumbai, August 4, 2020: Roche Diagnostics India today discussed the need for holistic preventive healthcare management, including timely lab investigations for people to manage life in COVID-19 times. 

Dr Sandeep Sewlikar, Medical and Scientific Affairs Head, Roche Diagnostics India, “The lockdown and the fear of COVID-19 infections has deferred regular health check-ups, especially amongst the population with co-morbidities. However, they are the same group of people who are at a higher risk of severe illness from COVID-19. Additionally, people with weakened immune system are also at increased risk. We are aware of multiple published reports that narrate the adverse impact of COVID-19 on physical, social and mental wellbeing. Hence, now more than ever, there is a need for preventive healthcare and steps towards boosting immunity.”

Dr Usha Sriram, Head of the Department, Diabetes and Endocrinology, Tag Center, VHS, Chennai said, “Importance of preventive health check-up becomes crucial during the current times. It is very important to eat healthy, stay active, sleep well and take less stress. Keeping a constant check on health helps people remain aware of various parameters that could play a role in minimising the risk of infection, especially for people with hypertension, diabetes and cardiovascular diseases. We have learnt that the severity and morbidity of COVID-19 symptoms and consequences increase for people with these health ailments. Hence, it is crucial for patients with co-morbidities to seek the support of preventive health based diagnostic tests in consultation with their physicians to manage their condition.”

Dr Anil Handoo, Senior Director, BLK Super Specialty Hospital, New Delhi, “The lockdown has modified our lifestyle and driven us towards an unhealthy diet and lack of exercise due to long hours indoors. In this context, it is important for all of us to return to undertaking routine health check-ups, while we make lifestyle and dietary changes. I would advise to remain connected with your physicians and provide them with results of some key tests like CBC, HbA1c, Lipid profile, Vitamin D, thyroid tests, liver function tests, kidney function tests and Vitamin B12, so that they may make informed decisions on enabling your health. Many hospitals and labs have currently regularised preventive health check services, to enable access to diagnostic solutions. Regular lab investigations cannot just prevent a person against severe COVID-19 related consequences but also against morbidity due to any other health ailment.”

With regular lab, investigations-based care, one can improve their body composition, blood lipid profile, improve blood glucose and maintain blood pressure within normal limits. It also helps in improving physical function and mobility.

Roche Diagnostics India has always been at the forefront of enabling patients’ access to quality diagnostic solutions, especially in the COVID-19 pandemic times. “Preventive healthcare has the potential to reduce the pressure on the already burdened healthcare system. The ongoing COVID-19 pandemic encourages the need for a paradigm shift from curative to preventive healthcare,” adds Dr Handoo. 

About Roche Diagnostics India

Roche Diagnostics India Pvt. Ltd. established in the year 2002 has offices located in Chennai, Delhi, Kolkata and Mumbai with over 400 employees. Our broad range of innovative diagnostic tests and systems play a pivotal role in the groundbreaking area of integrated healthcare solutions and cover early detection, targeted screening, evaluation and monitoring of disease. Roche Diagnostics India works with the objective of “Doing now what patients need next”, thus preparing for the nation’s future healthcare needs. To know more, visit go.roche.com/rdin.

For further information, please contact:

Roche Diagnostics India

Magline Rufina FR

Head – Communications

Phone: +91 8879927629

Email: magline.rufinafr@roche.com

 Anish Charles

Manager – Communications

Phone: +91 9820578421

Email: anish.charles@roche.com

Read more from the Health Issues India press office here.

Leave a Comment

Your email address will not be published. Required fields are marked *

%d bloggers like this: